Co-funding Institute(s):
National Cancer Institute (NCI)
Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
, June 2009
Bethesda, MD, United States
Contact for additional information: Dr. Michael R. Bishop, NCI 301-435-2764
DescriptionThe goals of the conference are: 1. Establish guidelines for the monitoring of relapse following allogeneic HSCT. Identification of high-risk populations (develop relapse index) Disease-specific monitoring techniques Schedule/frequency Data collection 2. Create recommendations for treatment of relapse following allogeneic HSCT. 3. Establish guidelines for the conduct of clinical trials for the treatment of relapse following allogeneic HSCT.